Evidence map›Paper›PMID 34850470›Full record

ArticleCell proliferation2022

m

Meijie Qi, Haifeng Sun, Yueshuai Guo, Yu Zhou, Xueying Gu, Jiachuan Jin, Xiaoxu Chen, Fangzhu Wang, Honghui Ma, Xuejiang Guo and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cell proliferation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 42 citations in OpenAlex.

  1. mJournal of assisted reproduction and genetics · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. IGF2BP3 recognizes mThe EMBO journal · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. m6A: a novel strategy for osteoporosis treatment.Frontiers in cell and developmental biology · 2025
    Review
  10. Review
  11. Reading the mCell & bioscience · 2024
    Review
  12. [The Roles of NSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2024
    Review
  13. Article
  14. RNA modifications in insects.Frontiers in insect science · 2024
    Review
  15. Landscape of mFrontiers in pharmacology · 2024
    Review
  16. Review
  17. Article
  18. Article
  19. The Role of NCancers · 2022
    Review
  20. Joint analysis of mFrontiers in endocrinology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Meijie QiState Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Haifeng SunState Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Yueshuai GuoState Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Yu ZhouState Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Xueying GuState Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Jiachuan JinState Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Xiaoxu ChenState Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Fangzhu WangReproductive Medicine Center, Gansu Provincial Maternity and Child-Care Hospital, Lanzhou, China.
Honghui MaDepartment of Cardiology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
Xuejiang GuoState Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Hao ChenDepartment of Human Cell Biology and Genetics, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
Bin ShenState Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.ORCID https://orcid.org/0000-0002-8946-8448
Nanjing Medical University · CNGansu Provincial Maternal and Child Health Hospital · CNNanjing Maternity and Child Health Care Hospital · CNShanghai East Hospital · CNSouthern University of Science and Technology · CNUniversity of Science and Technology of China · CN

Funding

National Key Research and Development Program of China 2016YFC1000600the National Natural Science Foundation of China 31970796
6 · The paper itself

Abstract

objectivesAccumulating evidences show that the regulatory network of m MATERIALS AND

methodsYthdf2 germ cell conditional knockout mice were obtained by crossing Ythdf2-floxed mice with Vasa-Cre and Stra8-Cre mice. Haematoxylin and eosin (HE) staining, immunofluorescent staining and Western blotting were used for phenotyping. CASA, IVF and ICSI were applied for sperm function analysis. RNA-seq, YTHDF2-RIP-seq and quantitative real-time PCR were used to explore transcriptome changes and molecular mechanism analysis.

resultsOur results showed that YTHDF2 was highly expressed in spermatogenic cells. The germ cell conditional knockout males were sterile, and their sperm displayed malformation, impaired motility, and lost fertilization ability. During differentiated spermatogonia transiting to pachytene spermatocyte, most m

conclusionOur data demonstrate that YTHDF2 facilitates the timely turnover of phase-specific transcripts to ensure the proper progression of spermatogenesis, which highlights a critical role of YTHDF2 in spermatogenesis.

Indexed as

AdenosineAnimalsFertilityFertilizationGene DeletionGerm CellsMaleMiceMice, Inbred C57BLMice, KnockoutRNA-Binding ProteinsRNA, MessengerSpermatogenesisSpermatozoaTranscriptomeAdenosineN-methyladenosineRNA-Binding ProteinsRNA, MessengerYTHDF2 protein, mousem6Amale sterilitymRNA clearancespermatogenesisYthdf2

Identifiers

PMID34850470
PMCPMC8780898
OpenAlexW3216679409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.